Concepedia

Publication | Open Access

Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers

26

Citations

31

References

2022

Year

Abstract

ClinicalTrials.gov, NCT02856425 . Registered August 4, 2016 - Prospectively registered.

References

YearCitations

Page 1